Cargando…
Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline Is Regulated by Different Cancer Stem Cell Populations
Malignant glioblastoma (GBM) is a highly aggressive brain tumor with a dismal prognosis and limited therapeutic options. Genomic profiling of GBM samples has identified four molecular subtypes (Proneural, Neural, Classical and Mesenchymal), which may arise from different glioblastoma stem-like cell...
Autores principales: | Garner, Jo Meagan, Ellison, David W., Finkelstein, David, Ganguly, Debolina, Du, Ziyun, Sims, Michelle, Yang, Chuan He, Interiano, Rodrigo B., Davidoff, Andrew M., Pfeffer, Lawrence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425556/ https://www.ncbi.nlm.nih.gov/pubmed/25955030 http://dx.doi.org/10.1371/journal.pone.0125838 |
Ejemplares similares
-
Correction: Molecular Heterogeneity in a Patient-Derived Glioblastoma Xenoline Is Regulated by Different Cancer Stem Cell Populations
por: Garner, Jo Meagan, et al.
Publicado: (2015) -
The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma
por: Ganguly, Debolina, et al.
Publicado: (2018) -
APELA Expression in Glioma, and Its Association with Patient Survival and Tumor Grade
por: Ganguly, Debolina, et al.
Publicado: (2019) -
Curcumin Potentiates Rhabdomyosarcoma Radiosensitivity by Suppressing NF-κB Activity
por: Orr, W. Shannon, et al.
Publicado: (2013) -
Brahma‐Related Gene‐1 (BRG1) promotes the malignant phenotype of glioblastoma cells
por: Wang, Yinan, et al.
Publicado: (2021)